CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-03 | Shiff Susan Ph.D. Director | Grant or award | +7,200 | 7,200 | ||
| 2021-06-03 | Shiff Susan Ph.D. Director | Grant or award · Stock Option (Right to Buy) | +10,800 | 10,800 | ||
| 2021-06-03 | Posner Christopher Director | Grant or award | +7,200 | 18,400 | ||
| 2021-06-03 | Posner Christopher Director | Grant or award · Stock Option (Right to Buy) | +10,800 | 10,800 | ||
| 2021-06-03 | Ives Jeffrey L. Director | Grant or award | +7,200 | 17,900 | ||
| 2021-06-03 | Ives Jeffrey L. Director | Grant or award · Stock Option (Right to Buy) | +10,800 | 10,800 | ||
| 2021-06-03 | BAINS HARRISON M JR Director | Grant or award | +7,200 | 20,400 | ||
| 2021-06-03 | BAINS HARRISON M JR Director | Grant or award · Stock Option (Right to Buy) | +10,800 | 10,800 | ||
| 2021-04-21 | Goncalves Joana Chief Medical Officer | Sale | −3,000 | $27.63 | $83K | 43,610 |
| 2021-03-30 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award | +16,000 | 67,342 | ||
| 2021-03-30 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Grant or award · Employee Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2021-03-30 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award | +16,000 | 135,319 | ||
| 2021-03-30 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Grant or award · Employee Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2021-03-30 | Goncalves Joana Chief Medical Officer | Grant or award | +16,000 | 46,610 | ||
| 2021-03-30 | Goncalves Joana Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2021-03-30 | CHALMERS DEREK T President & CEO | Grant or award | +52,000 | 1,002,511 | ||
| 2021-03-30 | CHALMERS DEREK T President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +103,000 | 103,000 | ||
| 2021-03-22 | Goncalves Joana Chief Medical Officer | Sale | −3,000 | $19.65 | $59K | 30,610 |
| 2021-03-05 | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D | Sale | −3,358 | $17.98 | $60K | 119,319 |
| 2021-03-05 | Terrillion Scott Sec'y; Chief Compliance & G.C. | Sale | −3,090 | $17.98 | $56K | 51,342 |
Page 10 of 15 · 284 trades